Publicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (10)

2012

  1. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses

    Vaccine, Vol. 30, Núm. 18, pp. 2848-2858

  2. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

    International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651

2011

  1. Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy

    Journal of Experimental Medicine, Vol. 208, Núm. 3, pp. 491-503

2010

  1. In vivo depletion of T lymphocyte-specific transcription factors by RNA interference

    Cell Cycle, Vol. 9, Núm. 14, pp. 2902-2907

  2. Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

    Vaccine, Vol. 28, Núm. 44, pp. 7146-7154

2007

  1. Calreticulin exposure dictates the immunogenicity of cancer cell death

    Nature Medicine, Vol. 13, Núm. 1, pp. 54-61

  2. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo

    Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756

2006

  1. A novel dendritic cell subset involved in tumor immunosurveillance

    Nature Medicine, Vol. 12, Núm. 2, pp. 214-219

  2. Apoptosis regulation in tetraploid cancer cells

    EMBO Journal, Vol. 25, Núm. 11, pp. 2584-2595

2005

  1. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

    Journal of Experimental Medicine, Vol. 202, Núm. 12, pp. 1691-1701